HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Evolus Evolution: HQ Move to Newport Center

Botox Competitor Takes Acacia’s SpaceBotox rival maker Evolus Inc. has moved its headquarters from Irvine to one of Newport Beach’s most exclusive office towers—and it appears to be getting a deal to do so.

Edwards Makes $100M Acquisition

CAS Medical’s technology “provides an important indicator of oxygen levels in the brain, which can enhance clinician decision-making,” said Katie Szyman, Edwards' corporate vice president, critical care, in a statement.

Tease photo

Biogennix names CFO

Biogennix, an Irvine-based maker of bone graft substitutes, appointed Robert Baizer as its first chief financial officer.

Tease photo

NextGen Q3 Profit Beats Estimates

NextGen Healthcare Inc. (Nasdaq: NXGN), the biggest publicly traded health care software provider based in Orange County, reported fiscal third quarter adjusted profit of 18 cents, which topped analyst expectations of 15 cents.

Tease photo

Spectrum Pharma to Sell Drug Portfolio

Spectrum Pharmaceutical Inc. (Nasdaq: SPPI) said today it has sold its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma LLC for up to $300 million.

Tease photo

Edwards, Boston Scientific Reach Deal

Shares of Edwards Lifesciences Corp. (NYSE: EW) climbed after the largest publicly traded company based in Orange County reached a settlement with rival Boston Scientific Corp. (NYSE: BSX).

Tease photo

Senior Housing Developers Pay $21M for IBC Site

DEVELOPMENT: SmartHome site eyed for congregate care

A Dallas-based developer of senior living properties has bought a 3-acre site along Barranca Parkway in Irvine, and plans to start construction later this year on one of the city’s largest and amenity-heavy residential complexes for older residents.

UCI Health Names COO

UCI Health appointed Chad Lefteris chief operating officer, effective Dec. 17.

Tease photo

MYnd Names New CEO

Mission Viejo-based MYnd Analytics Inc. (Nasdaq: MYND) appointed Patrick Herguth as chief executive officer, replacing George Carpenter who will assume the new role of chief innovation officer.

Tease photo

Mazzo Criminal Case Dismissed

“Mr. Mazzo, you must be very happy.”

Tease photo

No Mazzo Deal Yet

Late Tuesday, Judge David Carter ordered a second hearing, set for Thursday, before he will sign off on James Mazzo’s agreement with the Securities and Exchange Commission to settle insider trading charges.

Tease photo

Skyworks Shares Down on Guidance

Shares of Skyworks Solutions Inc. are down after the chipmaker provided December quarter revenue and earnings targets below Wall Street expectations.

Tease photo

Alteryx Q3 Revenue Up

Alteryx Inc. reported revenue increased 59% year-over-year to $54.2 million while posting a narrower loss of $244,000, compared to a loss of $3.3 million in the same period a year ago.

Tease photo

Masimo 3Q Sales up 8.9%

Masimo Corp. (Nasdaq: MASI) reported third quarter revenue climbed 8.9% to $210.6 million. Product sales grew 12% to $202.1 million for the quarter while royalty and other revenue declined 38% to $8.5 million.

Tease photo

Edwards: Sales Up, Shares Dip

Edwards Lifesciences Corp. (NYSE: EW) earned $226 million on sales of $907 million in its most recent quarter. Sales rose 10% year-over-year but missed expectations and its shares dipped 2% to a $30 billion market cap.

Tease photo

Spectrum Pharma Names CMO

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) named Francois Lebel as chief medical officer, overseeing the company’s clinical program including directing clinical trials and development as well as regulatory submissions.

Tease photo

Prev